This site is intended for healthcare professionals
Cardiovascular Metabolism Learning Zone
Declaration of sponsorship Novartis Pharma AG

Welcome

Declaration of sponsorship Novartis Pharma AG
Read time: 985 mins
Last updated:3rd Mar 2021
Type 2 diabetes and hypertension are independent risk factors for the development of cardiovascular disease which are associated with significant increases in morbidity and mortality. However, recent years have seen a substantial advance in both our understanding of the underlying pathophysiology of these conditions, but also in the management of both diseases.

The Cardiovascular Metabolism Learning Zone explores current thinking in the management of type 2 diabetes and hypertension with international experts offering their insights and opinions on topics such as clinical inertia and individualisation of management of type 2 diabetes, and combination therapy for the management of hypertension.

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest